These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9746840)

  • 21. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
    Ong EC
    Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible dangerous interaction of oxycontin and carisoprodol.
    Reeves RR; Mack JE
    Am Fam Physician; 2003 Jun; 67(11):2273. PubMed ID: 12800958
    [No Abstract]   [Full Text] [Related]  

  • 26. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
    Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
    Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer.
    Kampe S; Warm M; Kaufmann J; Hundegger S; Mellinghoff H; Kiencke P
    Curr Med Res Opin; 2004; 20(2):199-202. PubMed ID: 15006014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxycodone and the challenge of neuropathic cancer pain: a review.
    Núñez Olarte JM
    Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients.
    Ma K; Jiang W; Zhou Q; Du DP
    Int J Clin Pract; 2008 Feb; 62(2):241-7. PubMed ID: 18070045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In the grip of a deeper pain.
    Adler J
    Newsweek; 2003 Oct; 142(16):48-9. PubMed ID: 16124189
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
    Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
    Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fractures of vital teeth under chronic pain therapy with oxycodone].
    Schindler C; Schott G; Berthold H; Kirch W
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1878-9. PubMed ID: 16915551
    [No Abstract]   [Full Text] [Related]  

  • 40. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
    Ytterberg SR; Mahowald ML; Woods SR
    Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.